Calpro AS partner in a big national IBD study: BIOSTOP

Calpro participates in a big Norwegian study on UC patients : BIOSTOP. Our ELISA test kit CalproLab is used to measure calprotectin levels on parients in the study.

200 patients, divided into 28 centers across Norway, participate in the study
• The study will take place for 6 years
• Startup in April 2017
• Patient group: ulcerative colitis and usually anti-TNF treatment
• National Project Coordinator: Ingrid Prytz Berset
• Project sponsor: Helse Møre og Romsdal by Dag Arne Lihaug Hoff
• Project leader: Professor Knut Lundin University in Oslo / Rikshospitalet

Project Owners: University of Oslo, Institute of Clinical Medicine and Helse Møre og Romsdal.

Link to  project page Helse MR site (Norwegian language):
https://helse-mr.no/om-oss/nyheiter/nyheiter-2017/omfattande-forskingsprosjekt-starta-i-dag

CALPRO TEAM

General Information

Fecal calprotectin in differential diagnosis of irritable bowel syndrome

Li XG, Lv YM, Gu F, Yang XL., Department of Gastroenterology, Peking University Third May 9, 2015

Latest News

Calpro press release regarding MSD agreement

Please see the Calpro press release regarding MDS agreement for delivery of e-health technology CalproSmart:

Norsk | English October 13, 2016

Calprosmart in the Media

Please see our latest articles regarding CalproSmart in Aftenposten and LMF Norge

LMF Norge | Aftenposten October 12, 2016

View all latest

Share This